This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Warthin's tumour

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A Warthin's tumour is a benign tumour that occurs almost exclusively in the parotid glands, primarily in the tail. It accounts for about 5% of all parotid tumours. 10% occur bilaterally. It usually arises after middle age, with a male:female ratio of 5:1. There is a strong association with smoking.

It is composed of large glandular acini, embedded in dense lymphoid tissue in which lymphoid follicles may be seen. It is thought to arise from the salivary duct epithelium, the lymphoid tissue originating from the lymphoid aggregates present in the normal parotid gland.

The tumour presents as a soft, cystic lump. It alone, among salivary neoplasms, will concentrate technetium 99m. Warthin tumours are said to exude a highly-characteristic yellow or brown fluid if damaged.

Treatment is by superficial parotidectomy. Recurrence is rare but a satellite lesion may enlarge and present as another tumour. Prognosis after operation is good.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.